Automated Telephone System to Improve Treatment Adherence in People With Depression
Telecom System to Improve Adherence to Antidepressants
2 other identifiers
interventional
144
1 country
1
Brief Summary
This study will determine the efficacy of a computerized telephone system called Telephone-Linked Care (TLC) in improving adherence to antidepressant medication regimens in people with depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Apr 2003
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2003
CompletedFirst Submitted
Initial submission to the registry
August 25, 2005
CompletedFirst Posted
Study publicly available on registry
August 29, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2006
CompletedJuly 25, 2013
August 1, 2008
2.8 years
August 25, 2005
July 24, 2013
Conditions
Outcome Measures
Primary Outcomes (2)
Antidepressant medication adherence
Measured monthly for 4 months
Adherence to scheduled psychiatry clinic visits
Measured monthly for 4 months
Secondary Outcomes (2)
Depression status, measured by self-administered depression inventory scale
Measured at baseline and at 4 month follow-up
General health status, measured by self-rating health survey
Measured at baseline and at 4 month follow-up
Interventions
Eligibility Criteria
You may qualify if:
- A clinical diagnosis of major depressive disorder, dysthymic disorder, depressive disorder not otherwise specified, or any combination of the three
- Prescribed at least one antidepressant medication
- Access to a telephone with touch-tone service
- Speak and understand conversational English
You may not qualify if:
- Current significant alcohol or drug abuse
- Clinical diagnosis of bipolar disorder, schizoaffective disorder, or significant personality disorder
- Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), or other neurodegenerative diseases
- Alzheimer's disease and other dementia
- Cancer, undergoing radiation therapy or chemotherapy
- Suffering from Renal disease or on dialysis
- Immunologic disorder (rheumatoid arthritis, systemic lupus erythematosus \[SLE\], etc.)
- HIV
- Terminal illness
- Homeless
- Legally blind
- Planning to leave the geographic area during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Medical Centerlead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
Boston Medical Center
Boston, Massachusetts, 02118, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ramesh Farzanfar
Boston University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 25, 2005
First Posted
August 29, 2005
Study Start
April 1, 2003
Primary Completion
January 1, 2006
Study Completion
January 1, 2006
Last Updated
July 25, 2013
Record last verified: 2008-08